Our history

An awaited solution on an emerging market…

NAOGEN PHARMA is a Nantes-based radiopharmaceutical company founded in 2016 by Jean-François Chatal, a pioneer in nuclear medicine.

After a 45-year academic career, Jean-François CHATAL founded ATLAB PHARMA in 2008 (sold in 2018 to Telix Pharmaceuticals), NAOGEN PHARMA in 2016 and ATONCO in 2019.

… born along the development of the radiopharmaceutical hub of Nantes

Key steps of NAOGEN PHARMA history

• September 2016: Creation of Naogen Pharma
• 2023: Authorisation of pharmaceutical etablishment – manufacturer (GMP)
• 2023: Good manufacturing practices compliance certificate (GMP)
• 2023: Authorisation of pharmaceutical etablishment – operating